Abdullah Mamun

Mr. Abdullah Mamun

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2025 in Sensors
Verified
Journal Article
Open access
PDF file
Abdullah MamunAbdullah Mamun
Abdullah Mamun
AAAsiful Arefeen
Asiful Arefeen
Susan Beth RacetteSusan Beth Racette
Susan Beth Racette
Dorothy D SearsDorothy D Sears
Dorothy D Sears
CWCorrie Whisner
Corrie Whisner
HGHassan Ghasemzadeh
Hassan Ghasemzadeh
Postprandial hyperglycemia, marked by the blood glucose level exceeding the normal range after consuming a meal, is a critical indicator of progression toward type 2 diabetes in people with prediabetes and in healthy individuals. A key metric for understanding blood glucose dynamics after eating is the postprandial Area Under the Curve (AUC). Predicting postprandial AUC in advance based on a person’s lifestyle factors, such as diet and physical activity level, and explaining the factors that affect postprandial blood glucose could allow an individual to adjust their behavioral choices accordingly to maintain normal glucose levels. In this work, we develop an explainable machine learning solution, GlucoLens, that takes sensor-driven inputs and utilizes advanced data processing, large language models, and trainable machine learning models to estimate postprandial AUC and predict hyperglycemia from diet, physical activity, and recent glucose patterns. We use data obtained using wearables in a five-week clinical trial of 10 adults who worked full-time to develop and evaluate the proposed computational model that integrates wearable sensing, multimodal data, and machine learning. Our machine learning model takes multimodal data from wearable activity and glucose monitoring sensors, along with food and work logs, and provides an interpretable prediction of the postprandial glucose patterns. GlucoLens achieves a normalized root mean squared error (NRMSE) of 0.123 in its best configuration. On average, the proposed technology provides a 16% better predictive performance compared to the comparison models. Additionally, our technique predicts hyperglycemia with an accuracy of 79% and an F1 score of 0.749 and recommends different treatment options to help avoid hyperglycemia through diverse counterfactual explanations. With systematic experiments and discussion supported by established prior research, we show that our method is generalizable and consistent with clinical understanding.

6 March 2026 in Progress in Biomedical Engineering
Verified
Journal Article
Closed access
Abdullah MamunAbdullah Mamun
Abdullah Mamun
SSShovito Barua Soumma
Shovito Barua Soumma
HGHassan Ghasemzadeh
Hassan Ghasemzadeh
Ensuring trust in AI systems is essential for the safe and ethical integration of machine learning (ML) systems into high-stakes domains such as digital health. Key dimensions, including robustness, explainability, fairness, accountability, and privacy, need to be addressed throughout the AI lifecycle, from problem formulation and data collection to model deployment and human interaction. While various contributions address different aspects of trustworthy AI, a focused synthesis on robustness and explainability, especially tailored to the healthcare context, remains limited. This review addresses that need by organizing recent advancements into an accessible framework, highlighting both technical and practical considerations. We present a structured overview of methods, challenges, and solutions, aiming to support researchers and practitioners in developing reliable and explainable AI solutions for digital health. This review article is organized into three main parts. First, we introduce core pillars of trustworthy AI and discuss the technical and ethical challenges they pose, particularly in the context of digital health. Second, we explore application-specific trust considerations across domains such as intensive care, mental health, metabolic disease, and public health surveillance, highlighting how explainability, clinical validation, and human oversight support trust. Lastly, we present recent advancements in techniques aimed at improving robustness under data scarcity and distributional shifts, as well as explainable AI methods ranging from feature attribution to gradient-based interpretations and counterfactual explanations. This paper is further enriched with detailed discussions of the contributions toward robustness and explainability in digital health, the development of trustworthy AI systems in the era of LLMs, and various evaluation metrics for measuring trust and related parameters such as validity, fidelity, and diversity, offering a roadmap for building safer and more reliable AI systems.

11 April 2025 in Proceedings of the AAAI Conference on Artificial Intelligence
Verified
Journal Article
Open access
PDF file
Shovito Barua SoummaShovito Barua Soumma
Shovito Barua Soumma
Abdullah MamunAbdullah Mamun
Abdullah Mamun
HGHassan Ghasemzadeh
Hassan Ghasemzadeh
FuSE-MET addresses critical challenges in deploying human activity recognition (HAR) systems in uncontrolled environments by effectively managing noisy labels, sparse data, and undefined activity vocabularies. By integrating BERT-based word embeddings with domain-specific knowledge (i.e., MET values), FuSE-MET optimizes label merging, reducing label complexity and improving classification accuracy. Our approach outperforms the state-of-the-art techniques, including ChatGPT-4, by balancing semantic meaning and physical intensity.

29 July 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Abdullah MamunAbdullah Mamun
Abdullah Mamun
Shovito Barua SoummaShovito Barua Soumma
Shovito Barua Soumma
HGHassan Ghasemzadeh
Hassan Ghasemzadeh
Ensuring trust in AI systems is essential for the safe and ethical integration of machine learning systems into high-stakes domains such as digital health. Key dimensions, including robustness, explainability, fairness, accountability, and privacy, need to be addressed throughout the AI lifecycle, from problem formulation and data collection to model deployment and human interaction. While various contributions address different aspects of trustworthy AI, a focused synthesis on robustness and explainability, especially tailored to the healthcare context, remains limited. This review addresses that need by organizing recent advancements into an accessible framework, highlighting both technical and practical considerations. We present a structured overview of methods, challenges, and solutions, aiming to support researchers and practitioners in developing reliable and explainable AI solutions for digital health. This review article is organized into three main parts. First, we introduce the pillars of trustworthy AI and discuss the technical and ethical challenges, particularly in the context of digital health. Second, we explore application-specific trust considerations across domains such as intensive care, neonatal health, and metabolic health, highlighting how robustness and explainability support trust. Lastly, we present recent advancements in techniques aimed at improving robustness under data scarcity and distributional shifts, as well as explainable AI methods ranging from feature attribution to gradient-based interpretations and counterfactual explanations. This paper is further enriched with detailed discussions of the contributions toward robustness and explainability in digital health, the development of trustworthy AI systems in the era of LLMs, and various evaluation metrics for measuring trust and related parameters such as validity, fidelity, and diversity.

10 October 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Shovito Barua SoummaShovito Barua Soumma
Shovito Barua Soumma
Abdullah MamunAbdullah Mamun
Abdullah Mamun
HGHassan Ghasemzadeh
Hassan Ghasemzadeh
AI-powered wearable sensors are transforming remote health monitoring by enabling real-time diagnostics, personalized interventions and proactive disease management. This review synthesizes recent advances in AI-integrated biosensors across conditions such as diabetes, cardiovascular disease, neurodegenerative dis- orders, mental health, and maternal/neonatal care, while addressing challenges of scalability, privacy, interoperability, and model robustness. We highlight machine learning methods—including federated learning, transfer learning, and edge- AI—that enhance the processing of physiological signals i.e., glucose levels, gait patterns, and heart rate variability. Key innovations, including FDA-approved glucose monitors and digital twins for predictive health modeling, underscore the shift toward patient-centric and data-driven care. Yet, persistent gaps remain, including device heterogeneity, privacy concerns, and the need for adaptive models that generalize across populations. Emerging approaches such as large language models and counterfactual explanations provide contextualized insights and transparent decision-making. By bridging technical advances with clinical needs, this review charts a roadmap toward democratized, equitable, and precise healthcare.

20 March 2025 in arXiv
Verified
Preprint
Open access
PDF file
Abdullah MamunAbdullah Mamun
Abdullah Mamun
DCDiane J. Cook
Diane J. Cook
HGHassan Ghasemzadeh
Hassan Ghasemzadeh
Adherence to prescribed treatments is crucial for individuals with chronic conditions to avoid costly or adverse health outcomes. For certain patient groups, intensive lifestyle interventions are vital for enhancing medication adherence. Accurate forecasting of treatment adherence can open pathways to developing an on-demand intervention tool, enabling timely and personalized support. With the increasing popularity of smartphones and wearables, it is now easier than ever to develop and deploy smart activity monitoring systems. However, effective forecasting systems for treatment adherence based on wearable sensors are still not widely available. We close this gap by proposing Adherence Forecasting and Intervention with Machine Intelligence (AIMI). AIMI is a knowledge-guided adherence forecasting system that leverages smartphone sensors and previous medication history to estimate the likelihood of forgetting to take a prescribed medication. A user study was conducted with 27 participants who took daily medications to manage their cardiovascular diseases. We designed and developed CNN and LSTM-based forecasting models with various combinations of input features and found that LSTM models can forecast medication adherence with an accuracy of 0.932 and an F-1 score of 0.936. Moreover, through a series of ablation studies involving convolutional and recurrent neural network architectures, we demonstrate that leveraging known knowledge about future and personalized training enhances the accuracy of medication adherence forecasting. Code available: https://github.com/ab9mamun/AIMI.